Neko Health, co-founded by Spotify's Daniel Ek, has introduced its body scanning technology in New York after raising nearly $1 billion. The scans, which assess blood, skin, and metabolism, have generated significant interest, with a waitlist exceeding 300,000 globally. Currently priced at $500, the service is not covered by insurance but may qualify for Health Savings Accounts.
Investor Farooq Abbasi highlights the low utilization of preventative care in the U.S. and emphasizes the potential of Neko's advanced technology, which uses AI for improved health insights. While the company faces challenges in scaling and regulatory approval, there is optimism for future growth in the health tech sector.
With a significant waitlist and rising interest, Neko Health's body scanning service could reshape preventative care in the U.S. Watch for potential partnerships with healthcare providers and updates on regulatory approvals that may influence accessibility and pricing.